Hélène Sabatel

Direttore/Membro del Consiglio presso

DeuterOncology SA

Finance

Health Technology

Profilo

Hélène Sabatel currently works at DeuterOncology SA, as Director and Noshaq SA, as Investment Manager.

Società	Posizione	Inizio
DeuterOncology SA DeuterOncology SA BiotechnologyHealth Technology Operates as a preclinical-stage biotechnology company which focuses on the development of first-in-class dual MET and RAS pathway inhibitor for targeted cancer therapies	Direttore/Membro del Consiglio	-
Noshaq SA Noshaq SA Investment ManagersFinance Noshaq SA is an active manager which invests in companies located in Belgium with a focus on the Liège area. The firm targets companies operating across a broad range of sectors and industries. It provides financing for seed stage, early stage, later stage and growth stage.	Investitore di Private Equity	-

Attive

Inattive

Società nel listino

Aziende private

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Aziende private	2
Noshaq SA Noshaq SA Investment ManagersFinance Noshaq SA is an active manager which invests in companies located in Belgium with a focus on the Liège area. The firm targets companies operating across a broad range of sectors and industries. It provides financing for seed stage, early stage, later stage and growth stage.	Finance
DeuterOncology SA DeuterOncology SA BiotechnologyHealth Technology Operates as a preclinical-stage biotechnology company which focuses on the development of first-in-class dual MET and RAS pathway inhibitor for targeted cancer therapies	Health Technology